5 completed, 1 withdrawn. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 5, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Inh: new trials by email Literature Review of Inh trials Research Report on Inh
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam Isoniazid, Rifapentine, Rifampicin - Tuberculosis Infection | Phase 3 | Withdrawn | Freundeskreis Für Internationale Tuberkulosehilfe e.V | 2024-11-01 | 2026-09-09 | |
| Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care Bedaquiline Oral Tablet, Linezolid Oral Tablet, Delamanid in Oral Dosage Form - Tuberculosis, Pre-XDR-TB | Phase 3 | Completed | Wits Health Consortium (Pty) Ltd | 402 | 2019-08-22 | 2024-08-28 |
| An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis Linezolid, Bedaquiline, Levofloxacin - Tuberculosis, Multidrug Resistant Tuberculosis | Phase 2 / Phase 3 | Completed | University of Cape Town | 154 | 2015-11-12 | 2021-09-29 |
| Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention Weekly INH / RRT given by DOT - Silicosis, Tuberculosis | Phase 3 | Completed | Huashan Hospital | 566 | 2015-03-01 | 2020-06-30 |
| Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT Self Administered Therapy (SAT), SMS reminders, isoniazid and rifapentine - Latent Tuberculosis Infection | Phase 3 | Completed | Centers for Disease Control and Prevention | 1002 | 2012-09-01 | 2025-03-13 |
| Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection RPT + INH once weekly for 3 months given by DOT, Isoniazid (INH) daily for 9 months - Tuberculosis | Phase 3 | Completed | Centers for Disease Control and Prevention | 8053 | 2001-06-01 | 2024-08-27 |
Tuberculosis (5) · Extensively Drug-Resistant Tuberculosis (2) · Latent Tuberculosis (2) · Tuberculosis, Multidrug-Resistant (2) · Silicosis (1)
Centers for Disease Control and Prevention (2) · Freundeskreis Für Internationale Tuberkulosehilfe e.V (1) · Huashan Hospital (1) · University of Cape Town (1) · Wits Health Consortium (Pty) Ltd (1)
South Africa (3) · China (2) · Spain (2) · United States (2) · Brazil (1) · Canada (1) · Vietnam (1)
Andrey S Borisov, MD, MPH (1) · Elsa M Villarino, MD, MPH (1) · Francesca M Conradie (1) · Keertan Dheda, MBChB (1) · Robert Belknap, MD (1) · Timothy Sterling, MD (1) · Wenhong Zhang, MD,PhD (1)
PMID 29393655, PMID 22150035, PMID 25580725, PMID 25904367, PMID 26951571, PMID 27243774, PMID 28087928, PMID 29114781, PMID 31690107, PMID 31770617, PMID 31932382, PMID 32553881, PMID 34042560, PMID 35175905, PMID 36815322, PMID 38640958, PMID 40320069, PMID 42341301